Amedisys, Inc. (NASDAQ:AMED) Shares Purchased by Xponance Inc.

Xponance Inc. increased its stake in shares of Amedisys, Inc. (NASDAQ:AMED) by 9.3% during the 4th quarter, Holdings Channel.com reports. The fund owned 4,454 shares of the health services provider’s stock after purchasing an additional 378 shares during the quarter. Xponance Inc.’s holdings in Amedisys were worth $423,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors have also recently bought and sold shares of the company. Contravisory Investment Management Inc. acquired a new position in Amedisys in the fourth quarter valued at $258,000. Argonautica Private Wealth Management Inc. increased its stake in Amedisys by 6.1% in the third quarter. Argonautica Private Wealth Management Inc. now owns 3,003 shares of the health services provider’s stock valued at $280,000 after purchasing an additional 172 shares during the period. Federated Hermes Inc. increased its stake in Amedisys by 32.9% in the fourth quarter. Federated Hermes Inc. now owns 3,518 shares of the health services provider’s stock valued at $334,000 after purchasing an additional 871 shares during the period. MRP Capital Investments LLC acquired a new position in Amedisys in the third quarter valued at $337,000. Finally, Commonwealth Equity Services LLC increased its stake in Amedisys by 2.9% in the third quarter. Commonwealth Equity Services LLC now owns 3,896 shares of the health services provider’s stock valued at $364,000 after purchasing an additional 110 shares during the period. 94.36% of the stock is currently owned by institutional investors and hedge funds.

Analysts Set New Price Targets

A number of research analysts have commented on the stock. Raymond James restated a “market perform” rating on shares of Amedisys in a research note on Tuesday, March 26th. Cantor Fitzgerald restated a “neutral” rating and issued a $101.00 price objective on shares of Amedisys in a research note on Thursday. StockNews.com lowered shares of Amedisys from a “buy” rating to a “hold” rating in a research note on Friday. Finally, Royal Bank of Canada boosted their price target on shares of Amedisys from $97.00 to $100.00 and gave the stock an “outperform” rating in a research note on Monday, March 25th. Eight investment analysts have rated the stock with a hold rating and one has assigned a buy rating to the company’s stock. According to MarketBeat.com, the company has an average rating of “Hold” and an average target price of $97.50.

Amedisys Trading Up 0.7 %

Shares of Amedisys stock opened at $91.79 on Friday. Amedisys, Inc. has a 52-week low of $73.10 and a 52-week high of $96.44. The company has a quick ratio of 1.05, a current ratio of 1.05 and a debt-to-equity ratio of 0.32. The company’s 50-day simple moving average is $92.54 and its 200-day simple moving average is $93.35. The firm has a market cap of $3.00 billion, a price-to-earnings ratio of -143.42, a price-to-earnings-growth ratio of 4.29 and a beta of 0.86.

Amedisys (NASDAQ:AMED) last released its quarterly earnings data on Wednesday, April 24th. The health services provider reported $1.03 EPS for the quarter, topping analysts’ consensus estimates of $1.02 by $0.01. The firm had revenue of $571.41 million for the quarter, compared to the consensus estimate of $565.38 million. Amedisys had a negative net margin of 0.91% and a positive return on equity of 13.00%. The firm’s revenue was up 2.7% on a year-over-year basis. During the same quarter in the previous year, the firm earned $1.00 earnings per share. As a group, equities research analysts anticipate that Amedisys, Inc. will post 4.54 earnings per share for the current year.

About Amedisys

Amedisys, Inc, together with its subsidiaries, provides healthcare services in the United States. It operates through three segments: Home Health, Hospice, and High Acuity Care. The Home Health segment offers a range of services in the homes of individuals for the recovery of patients from surgery, chronic disability, or terminal illness, as well as prevents avoidable hospital readmissions through its skilled nurses; nursing services, rehabilitation therapists specialized in physical, speech, and occupational therapy; and social workers and aides for assisting its patients.